Navigation Links
Advanced Instruments Signs License and Sensor Development Agreement With Cantimer, Inc.
Date:2/23/2010

MENLO PARK, Calif. and NORWOOD, Mass., Feb. 23 /PRNewswire/ -- Cantimer, Inc., and Advanced Instruments, Inc. today jointly announced that the two companies had signed a license and product development agreement. Under the terms of the license agreement, Advanced Instruments received an exclusive license to Cantimer's unique sensor technology for select applications in the biotech market. The Companies also entered into a Product Development Agreement for Cantimer to develop a specific sensor to integrate into Advanced Instruments' products for in-situ monitoring of osmolality in bioreactors and fermenters. The companies anticipate that a long term sensor supply agreement will follow the joint development effort and that developed products will be sold to end-users through Advanced Instruments' existing commercial network.  

"Monitoring osmolality is a critical control parameter in the biotech market. Traditionally this has been accomplished using discreet samples on a laboratory instrument. Cantimer's unique sensor technology makes it possible to measure osmolality in the bioreactor and in real time, reducing the possibility of product contamination and enabling tighter product quality control" said John Coughlin, CEO of Advanced Instrum
'/>"/>

SOURCE Cantimer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
2. Advanced Life Sciences Previews 2010 Milestones
3. EPA Reaffirms Sugarcane Biofuel is Advanced Renewable Fuel with 61% Less Emissions than Gasoline
4. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
5. Æterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced Waldenstroms Macroglobulinemia
6. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
7. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
8. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
9. Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures
10. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
11. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... OAK RIDGE, Tenn., July 24, 2014 -- A novel ... at the Department of Energy,s Oak Ridge National Laboratory ... known for its unusual physical and electrochemical properties. ... examined how oxygen affects the surface of a perovskite ... electronic behavior. The new avenue to understand surface behavior ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
(Date:7/24/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering.  ... is the in vitro growth of plant or animal ... and biopharmaceutical production. Cell culture is a crucial step ... and cell culture consumables are necessary for the in ...
(Date:7/24/2014)... Three companies from the angelMD network were ... Competition. Out of 700 competition entrants, Chiron Health, Litesprite, ... round. In this round twenty teams are invited to ... mentoring from thought-leaders and medical entrepreneurs from all over ... commitment to the Livestrong vision around the Big C ...
Breaking Biology Technology:ORNL study reveals new characteristics of complex oxide surfaces 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... ANTONIO, March 30 BioMedical Enterprises, Inc. (BME), a ... development of orthopaedic memory metal implants, announced today that ... President, Sales and Marketing. BME specializes in nitinol ... bone ends together to promote bone union. The ...
... DIEGO, CA, March 30, 2009 Senomyx, Inc. (Nasdaq: ... using proprietary technologies to discover and develop novel flavor ... announced today the extension of the collaborative research phase ... Campbell Soup Company, a global manufacturer and marketer of ...
... final study data to FDA for cervical cancer vaccinePHILADELPHIA ... GSK ) today provided the following update regarding its ... for approval of CERVARIX(R), its vaccine to prevent cervical ... 16 and 18.GSK has submitted final data from its ...
Cached Biology Technology:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing 2SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY 2SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY 3CERVARIX(R) U.S. Regulatory Update 2CERVARIX(R) U.S. Regulatory Update 3
(Date:7/25/2014)... 2014)The link between autism and disrupted brain development ... the disease, and is largely unknown. However, thanks ... Initiative (SFARI), George Washington University (GW) researcher Anthony-Samuel ... integrative and in-depth answers to these key questions ... LaMantia, professor of pharmacology and physiology at the ...
(Date:7/25/2014)... increasingly consume the healthcare community and remain ... , To address the worldwide crisis of ... countries, global leaders in diabetes, epidemiology and ... prevention and development of diverse intervention programs ... , This book on "Global Health Perspectives ...
(Date:7/25/2014)... tractography (DTT), which is derived from diffusion tensor ... motor tracts, such as the corticospinal tract, the ... The corticospinal tract is known to be a ... human brain. Several studies have reported on injury ... addition, some studies have demonstrated recovery of a ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2What constitutes an effective response to the global 'diabesity' tsunami? 2
... less than two weeks, Amanda Cobbs-Russell, a junior majoring in ... the adventure of a lifetime, requiring her to push herself ... of only five people two Americans and three Canadians ... to hike, eat, and sleep among sweeping glaciers, polar ice ...
... American Society for Microbiology (ASM) ICAAC Young Investigator Award ... College London. Sponsored by the ASM, this award ... and infectious diseases. Dr. Grndling,s initial work focused ... the membrane and how S monomers interact. She constructed ...
... state of upheaval, it is expected that they might take refuge ... milkshake? Not so, says Stacy L. Wood, Associate ... South Carolina. In fact, in a study to be published ... when people are in a state of upheaval, they,re more likely ...
Cached Biology News:UC Riverside student is 1 of only 5 persons selected for challenging Arctic expedition 2UC Riverside student is 1 of only 5 persons selected for challenging Arctic expedition 3
... NaCl, 20mM MOPS, pH 7.5, 60mM ... EGTA, 10 Properites: For selective in ... chromatography, divalent cation activation plus trypsin ... Assurance: routinely evaluated by dephosphorylation of ...
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
HNF-1 Purified Anti-Mouse, Anti-Rat, Anti-Rabbit, Anti-Human clone 2, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Recombinant Porcine IL-1 alpha/IL-1F1, CF...
Biology Products: